Abstract
Background
Experimental autoimmune encephalomyelitis (EAE) is a fatal autoimmune disease, and microRNAs (miRNAs) play vital roles in regulating immune responses.
Objectives
This study aimed to explore the effect of miR-20b-5p in mice with EAE as well as the underlying mechanism.
Methods
An EAE mouse model was established via myelin oligodendrocyte glycoprotein (MOG)35–55 peptide induction, and miR-20b-5p expression was measured. Then, miR-20b-5p agomiR was injected via the caudal vein. Clinical score evaluation, body weight measurement, and histological staining were performed, and lactic dehydrogenase (LDH), superoxide dismutase (SOD), catalase (CAT) and reactive oxygen species (ROS) levels were measured. The binding of miR-20b-5p to Nod-like receptor protein 3 (NLRP3) was analysed by dual-luciferase assay. Levels of NLRP3, ASC and caspase-1 were measured. The effect of NLRP3 on EAE model mice was analysed via rescue experiments.
Results
The clinical scores and body weight of EAE model mice were reduced, and tissue damage was exacerbated. miR-20b-5p was expressed at low levels in EAE model mice, and their symptoms were ameliorated after miR-20b-5p overexpression. Moreover, miR-20b-5p overexpression alleviated pyroptosis, inflammation and oxidative stress in the spinal cord tissues of EAE model mice. Mechanistically, miR-20b-5p targeted NLRP3 transcription and inhibited NLRP3/ASC/caspase-1 pathway activation. NLRP3 overexpression activated the NLRP3/ASC/caspase-1 pathway and abolished the protective effect of miR-20b-5p on EAE.
Conclusion
miR-20b-5p exerted a protective effect on EAE in mice by inhibiting NLRP3 transcription and NLRP3/ASC/caspase-1 pathway activation.
Similar content being viewed by others
Data availability
The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.
References
Baltimore D, Boldin MP, O’Connell RM, Rao DS, Taganov KD (2008) MicroRNAs: new regulators of immune cell development and function. Nat Immunol 9(8):839–845
Barclay W, Shinohara ML (2017) Inflammasome activation in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE). Brain Pathol 27(2):213–219
Bjelobaba I, Begovic-Kupresanin V, Pekovic S, Lavrnja I (2018) Animal models of multiple sclerosis: focus on experimental autoimmune encephalomyelitis. J Neurosci Res 96(6):1021–1042
Chopra N, Wang R, Maloney B, Nho K, Beck JS, Pourshafie N, Niculescu A, Saykin AJ, Rinaldi C, Counts SE et al (2021) MicroRNA-298 reduces levels of human amyloid-beta precursor protein (APP), beta-site APP-converting enzyme 1 (BACE1) and specific tau protein moieties. Mol Psychiatry 26(10):5636–5657
Chu F, Shi M, Lang Y, Shen D, Jin T, Zhu J, Cui L (2018) Gut Microbiota in multiple sclerosis and experimental autoimmune encephalomyelitis: current applications and future perspectives. Mediators Inflamm 2018:8168717
Constantinescu CS, Farooqi N, O’Brien K, Gran B (2011) Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). Br J Pharmacol 164(4):1079–1106
Fan X, Zhan E, Yao Y, Zhang R, Sun Y, Tian X (2021) MiR-599 protects cardiomyocytes against oxidative stress-induced pyroptosis. Biomed Res Int 2021:3287053
Fletcher JM, Lalor SJ, Sweeney CM, Tubridy N, Mills KH (2010) T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin Exp Immunol 162(1):1–11
Fraga-Silva TF, Mimura LA, Marchetti CM, Chiuso-Minicucci F, Franca TG, Zorzella-Pezavento SF, Venturini J, Arruda MS, Sartori A (2015) Experimental autoimmune encephalomyelitis development is aggravated by Candida albicans infection. J Immunol Res 2015:635052
Glatigny S, Bettelli E (2018) Experimental Autoimmune Encephalomyelitis (EAE) as Animal Models of Multiple Sclerosis (MS). Cold Spring Harb Perspect Med 8 (11)
Gu C (2016) KIR4.1: K(+) Channel Illusion or Reality in the Autoimmune Pathogenesis of Multiple Sclerosis. Front Mol Neurosci 9 90.
Guide for the Care and Use of Laboratory Animals. 8th ed, Washington (DC) (2011)
Hou H, Miao J, Cao R, Han M, Sun Y, Liu X, Guo L (2017) Rapamycin ameliorates experimental autoimmune encephalomyelitis by suppressing the mTOR-STAT3 pathway. Neurochem Res 42(10):2831–2840
Hou B, Zhang Y, Liang P, He Y, Peng B, Liu W, Han S, Yin J, He X (2020) Inhibition of the NLRP3-inflammasome prevents cognitive deficits in experimental autoimmune encephalomyelitis mice via the alteration of astrocyte phenotype. Cell Death Dis 11(5):377
Ingwersen J, Menge T, Wingerath B, Kaya D, Graf J, Prozorovski T, Keller A, Backes C, Beier M, Scheffler M et al (2015) Natalizumab restores aberrant miRNA expression profile in multiple sclerosis and reveals a critical role for miR-20b. Ann Clin Transl Neurol 2(1):43–55
Inoue M, Shinohara ML (2013) NLRP3 Inflammasome and MS/EAE. Autoimmune Dis 2013:859145
Jahan-Abad AJ, Karima S, Shateri S, Baram SM, Rajaei S, Morteza-Zadeh P, Borhani-Haghighi M, Salari AA, Nikzamir A, Gorji A (2020) Serum pro-inflammatory and anti-inflammatory cytokines and the pathogenesis of experimental autoimmune encephalomyelitis. Neuropathology 40(1):84–92
Juzwik CA, Drake S, Lecuyer MA, Johnson RM, Morquette B, Zhang Y, Charabati M, Sagan SM, Bar-Or A, Prat A et al (2018) Neuronal microRNA regulation in experimental autoimmune encephalomyelitis. Sci Rep 8(1):13437
Kiasalari Z, Afshin-Majd S, Baluchnejadmojarad T, Azadi-Ahmadabadi E, Esmaeil-Jamaat E, Fahanik-Babaei J, Fakour M, Fereidouni F, Ghasemi-Tarie R, Jalalzade-Ogvar S et al (2021a) Ellagic acid ameliorates neuroinflammation and demyelination in experimental autoimmune encephalomyelitis: Involvement of NLRP3 and pyroptosis. J Chem Neuroanat 111:101891
Kiasalari Z, Afshin-Majd S, Baluchnejadmojarad T, Azadi-Ahmadabadi E, Fakour M, Ghasemi-Tarie R, Jalalzade-Ogvar S, Khodashenas V, Tashakori-Miyanroudi M, Roghani M (2021b) Sinomenine alleviates murine experimental autoimmune encephalomyelitis model of multiple sclerosis through inhibiting NLRP3 inflammasome. J Mol Neurosci 71(2):215–224
Lassmann H, Bradl M (2017) Multiple sclerosis: experimental models and reality. Acta Neuropathol 133(2):223–244
Li Z, Liu F, He X, Yang X, Shan F, Feng J (2019) Exosomes derived from mesenchymal stem cells attenuate inflammation and demyelination of the central nervous system in EAE rats by regulating the polarization of microglia. Int Immunopharmacol 67:268–280
Li Y, Nourbakhsh N, Pham H, Tham R, Zuckerman JE, Singh P (2020) Evolution of altered tubular metabolism and mitochondrial function in sepsis-associated acute kidney injury. Am J Physiol Renal Physiol 319(2):F229–F244
Liu F, Li Z, He X, Yu H, Feng J (2019) Ghrelin Attenuates neuroinflammation and demyelination in experimental autoimmune encephalomyelitis involving NLRP3 inflammasome signaling pathway and pyroptosis. Front Pharmacol 10:1320
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4):402–408
Lou J, Wang Y, Zhang Z, Qiu W (2017) MiR-20b inhibits mycobacterium tuberculosis induced inflammation in the lung of mice through targeting NLRP3. Exp Cell Res 358(2):120–128
Meza-Sosa KF, Valle-Garcia D, Pedraza-Alva G, Perez-Martinez L (2012) Role of microRNAs in central nervous system development and pathology. J Neurosci Res 90(1):1–12
Murphy AC, Lalor SJ, Lynch MA, Mills KH (2010) Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis. Brain Behav Immun 24(4):641–651
Robinson AP, Harp CT, Noronha A, Miller SD (2014) The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment. Handb Clin Neurol 122:173–189
Shaw PJ, Lukens JR, Burns S, Chi H, McGargill MA, Kanneganti TD (2010) Cutting edge: critical role for PYCARD/ASC in the development of experimental autoimmune encephalomyelitis. J Immunol 184(9):4610–4614
Shen C, Zhang Z, Xie T, Xu J, Yan J, Kang A, Dai Q, Wang S, Ji J, Shan J (2018) Jinxin oral liquid inhibits human respiratory syncytial virus-induced excessive inflammation associated with blockade of the NLRP3/ASC/caspase-1 pathway. Biomed Pharmacother 103:1376–2138
Singh RP, Massachi I, Manickavel S, Singh S, Rao NP, Hasan S, Mc Curdy DK, Sharma S, Wong D, Hahn BH et al (2013) The role of miRNA in inflammation and autoimmunity. Autoimmun Rev 12(12):1160–1165
Song L, Pei L, Yao S, Wu Y, Shang Y (2017) NLRP3 inflammasome in neurological diseases, from functions to therapies. Front Cell Neurosci 11:63
Sun L, Ma W, Gao W, Xing Y, Chen L, Xia Z, Zhang Z, Dai Z (2019) Propofol directly induces caspase-1-dependent macrophage pyroptosis through the NLRP3-ASC inflammasome. Cell Death Dis 10(8):542
Urwanisch L, Luciano M, Horejs-Hoeck J (2021) The NLRP3 inflammasome and its role in the pathogenicity of Leukemia. Int J Mol Sci 22(3):2171
Wang R, Lahiri DK (2022) Effects of microRNA-298 on APP and BACE1 translation differ according to cell type and 3’-UTR variation. Sci Rep 12(1):3074
Wang S, Yuan YH, Chen NH, Wang HB (2019) The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in Parkinson’s disease. Int Immunopharmacol 67:458–464
Wang S, Du S, Lv Y, Wang W, Zhang F (2020) Elevated microRNA-20b-3p and reduced thioredoxin-interacting protein ameliorate diabetic retinopathy progression by suppressing the NLRP3 inflammasomes. IUBMB Life 72(7):1433–1448
Wang R, Chopra N, Nho K, Maloney B, Obukhov AG, Nelson PT, Counts SE, Lahiri DK (2022) Human microRNA (miR-20b-5p) modulates Alzheimer’s disease pathways and neuronal function, and a specific polymorphism close to the MIR20B gene influences Alzheimer’s biomarkers. Mol Psychiatry 27(2):1256–1273
Weaver A, Goncalves da Silva A, Nuttall RK, Edwards DR, Shapiro SD, Rivest S, Yong VW (2005) An elevated matrix metalloproteinase (MMP) in an animal model of multiple sclerosis is protective by affecting Th1/Th2 polarization. FASEB J 19(12):1668–1670
Wu X, Zhang H, Qi W, Zhang Y, Li J, Li Z, Lin Y, Bai X, Liu X, Chen X et al (2018) Nicotine promotes atherosclerosis via ROS-NLRP3-mediated endothelial cell pyroptosis. Cell Death Dis 9(2):171
Wu L, Xia J, Li D, Kang Y, Fang W, Huang P (2020) Mechanisms of M2 Macrophage-Derived Exosomal Long Non-coding RNA PVT1 in Regulating Th17 Cell Response in Experimental Autoimmune Encephalomyelitisa. Front Immunol 11:1934
Xue Z, Zhang Z, Liu H, Li W, Guo X, Zhang Z, Liu Y, Jia L, Li Y, Ren Y et al (2019) lincRNA-Cox2 regulates NLRP3 inflammasome and autophagy mediated neuroinflammation. Cell Death Differ 26(1):130–145
Zhang GX, Gran B, Yu S, Li J, Siglienti I, Chen X, Kamoun M, Rostami A (2003) Induction of experimental autoimmune encephalomyelitis in IL-12 receptor-beta 2-deficient mice: IL-12 responsiveness is not required in the pathogenesis of inflammatory demyelination in the central nervous system. J Immunol 170(4):2153–2160
Zhang F, Yang J, Jiang H, Han S (2014) An alphanubeta3 integrin-binding peptide ameliorates symptoms of chronic progressive experimental autoimmune encephalomyelitis by alleviating neuroinflammatory responses in mice. J Neuroimmune Pharmacol 9(3):399–412
Zhu E, Wang X, Zheng B, Wang Q, Hao J, Chen S, Zhao Q, Zhao L, Wu Z, Yin Z (2014) miR-20b suppresses Th17 differentiation and the pathogenesis of experimental autoimmune encephalomyelitis by targeting RORgammat and STAT3. J Immunol 192(12):5599–5609
Acknowledgements
Not applicable.
Funding
No relevant funding was received.
Author information
Authors and Affiliations
Contributions
FZ and FW: conceived and designed the experiments. FZ, XW, SY, WT, and OL: performed the experiments. FZ, XW, and WT: wrote the manuscript. All authors read and approved the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
Fenggang Zhou, Fei Wu, Xinran Wang, Shihua Yu, Wenqi Tian, and Ou Lv declares that has no conflict of interest.
Ethical approval
All animal experiments were conducted in compliance with the guidelines for experimental animal care and use (2011), and were approved by the Ethic Committee of The Second Affiliated Hospital of Harbin Medical University (SYDW2023-043). Adequate measures were taken to minimize animal suffering. All procedures were strictly implemented by the code of ethics.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Zhou, F., Wu, F., Wang, X. et al. miR-20b-5p exerts protective effects against experimental autoimmune encephalomyelitis in mice by inhibiting NLRP3 transcription and NLRP3/ASC/caspase-1 axis activation. Mol. Cell. Toxicol. (2023). https://doi.org/10.1007/s13273-023-00398-3
Accepted:
Published:
DOI: https://doi.org/10.1007/s13273-023-00398-3